To date, one of the most challenging aspects of Oculoplastic practice is socket management, due to the range of presentations and issues involved. The condition of an exposed orbital implant is a particularly complex issue when it comes to socket surgery.
With over 20 years of high-volume clinical experience, Dr Looi will speak on the condition of an exposed orbital implant during the course. The course outline is as follows:
Dr Looi is the Medical Director at Ava Eye Clinic, an eye clinic in Singapore specialising in general eye care and oculoplastic services. Some of the services provided by the clinic are general eye care services including glaucoma, diabetic eye assessment, cataract surgery in Singapore and more. The clinic also provides oculoplastic services such as ptosis surgery, double eyelid surgery, epiblepharon surgery, socket surgery and orbital surgery.
At Ava Eye Clinic, Dr Looi leads her team with her experience as the Head of the Oculoplastic Department and Clinical Director of the General Eye Clinic at the Singapore National Eye Centre. The team comprises dedicated medical and optometry staff that are committed to delivering premium eye care services for their patients. With her experience and expertise in treating the entire spectrum of oculoplastic conditions, Dr Looi will share more on the challenging condition during the course.
You may sign up for the course at https://2023.apaophth.org/registration/.
Hashtag: #AvaEyeClinic #EyeClinic #Ophthalmology
The issuer is solely responsible for the content of this announcement.
ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…
Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…
QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…
DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…
Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…